Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
avelumab (bavencio) (1 trial)
axitinib (inlyta) (1 trial)
palbociclib (ibrance) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (3 total)